Gluten Related News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boca ratonUnited statesJack syageJames sapirsteinJennifer sealy voyksnerLiz phillipsDrug administrationFirst wave bio incSociety for surgery of the alimentary tractExchange commissionGi divisionAmerican society for gastrointestinal endoscopyAmerican gastroenterological associationEntero therapeutics incCompany annual report on formTherapeutics presents two posters

MyJournals org - Science - Skin gluten-related disorders: new and old cutaneous manifestations to be considered (Frontiers in Medicine)

MyJournals.org - Science - Skin gluten-related disorders: new and old cutaneous manifestations to be considered (Frontiers in Medicine)

Gluten related

Immunic Inc (IMUX) Presents Clinical and Preclinical Data for IMU-856

Immunic Inc (IMUX) Presents Clinical and Preclinical Data for IMU-856
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittHella kohlhofFranziska buriImmunic incDigestive disease weekChief scientific officerChief executive officerSenior medical directorFirst in human trialPoster numberGluten related

EQS-News: Immunic, Inc : Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

Issuer: Immunic, Inc. / Key word(s): Study/Conference Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action 06.05.2023

United statesPaula schwartzHella kohlhofJessica breuFranziska buriDaniel vittEdna kaplanExchange commissionDistribution servicesImmunic incRx communications groupPresents clinicalPreclinical dataDigestive disease weekIncluding its molecular modeOrally available

Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesDaniel vittEdna kaplanHella kohlhofFranziska buriPaula schwartzJessica breuPrnewswire immunic incRx communications groupExchange commissionImmunic incOrally availableSystemically actingHighly selectivePotent small molecule modulatorTargets regeneration